| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/03/2002 | EP1218407A1 Uses of kappa-conotoxin pviia |
| 07/03/2002 | EP1218406A1 Nucleic acids and secreted polypeptides encoded thereby |
| 07/03/2002 | EP1218405A2 Nucleic acid molecule comprising a nucleic acid sequence coding for a hemocyanin |
| 07/03/2002 | EP1218404A1 A binding motif of a receptor |
| 07/03/2002 | EP1218400A1 Compositions and methods for the diagnosis and treatment of immune disorders |
| 07/03/2002 | EP1218399A1 Cacna1g polynucleotide, polypeptide and methods of use therefor |
| 07/03/2002 | EP1218397A1 Attractin-like polynucleotides, polypeptides, and antibodies |
| 07/03/2002 | EP1218394A1 Differentially expressed genes associated with her-2/neu overexpression |
| 07/03/2002 | EP1218393A1 Cell targeting compositions and methods of using the same |
| 07/03/2002 | EP1218392A1 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses |
| 07/03/2002 | EP1218036A1 Cell based assay |
| 07/03/2002 | EP1218031A2 Pharmaceutical composition comprising an antigen |
| 07/03/2002 | EP1218029A1 Use of an outer membrane protein a of an enterobacterium associated with a rsv immunogenic peptide for preparing vaccines for intranasal administration |
| 07/03/2002 | EP1218019A2 Oncolytic virus |
| 07/03/2002 | EP1217891A1 Therapeutic methods and compositions using viruses of the recombinant paramyxoviridae family |
| 07/03/2002 | EP1181351A4 Method of purifying heterologous proteins |
| 07/03/2002 | EP1049716A4 Purification of fibrinogen |
| 07/03/2002 | EP1012174A4 Nik proteins, nucleic acids and methods |
| 07/03/2002 | EP0938326A4 Synthetic phosphopeptides for treating bone diseases |
| 07/03/2002 | EP0892854B1 Assays and reagents for identifying anti-fungal agents, and uses related thereto |
| 07/03/2002 | EP0754054B1 Antirestenosis protein |
| 07/03/2002 | EP0578746B1 GENES WHICH INFLUENCE $i(PICHIA) PROTEOLYTIC ACTIVITY, AND USES THEREFOR |
| 07/03/2002 | EP0437576B1 Homologous recombination for universal donor cells and chimeric mammalian hosts |
| 07/03/2002 | CN1357109A Removal of prions from blood, plasma and other liquids |
| 07/03/2002 | CN1357049A Receptor based antagonists and mehtods of making and using |
| 07/03/2002 | CN1357047A Recombinant fusion protein (vaccine) compsn. contg. same and method for prodn. thereof |
| 07/03/2002 | CN1357045A Outer surface proteins, their genes, and their use |
| 07/03/2002 | CN1357044A RNP originating in paramyxovirus |
| 07/03/2002 | CN1357043A Avirulent xanthomonas-campestris strains producing xanthan |
| 07/03/2002 | CN1357042A Interleukin-17 related mammalian cytokines, polynucleotides encoding them. uses |
| 07/03/2002 | CN1357041A Head trauma induced cytoplasmatic calcium binding protein |
| 07/03/2002 | CN1357008A Method for stabilising proteins in complex mixtures during thier storage in aqueous solvents |
| 07/03/2002 | CN1357007A Expression of heparin-binding protein in recombinant mammalian cells |
| 07/03/2002 | CN1357006A Mage-A1 peptides presented by HLA class II molecules |
| 07/03/2002 | CN1357005A Process for partitioning of proteins |
| 07/03/2002 | CN1356906A Therapeutic methods and compsns. for treatment of in paired interpersonal and behavioral disorders |
| 07/03/2002 | CN1356339A High-expression gene of liver cancer, protein coded by it and its application |
| 07/02/2002 | US6414220 Galanin transgenic mice |
| 07/02/2002 | US6414132 Method of eliminating inhibitory/instability regions of mRNA |
| 07/02/2002 | US6414131 Nucleic acid sequence; schizophrenia, bipolar disorder and depression |
| 07/02/2002 | US6414130 Polypeptides binds to extracellular domain, glycosylated polypeptide or monoclonal antibody; antitumor agents |
| 07/02/2002 | US6414129 Cells containing expression vectors; diagnosis; immunomodulator detection; genetic engineering |
| 07/02/2002 | US6414128 Leptin ligand binding; medical diagnosis, therapy, agonists, and antagonists; genetic engineering |
| 07/02/2002 | US6414125 Adsorption on avid collagen immobilized to denatured carrier; separation, elution; recovering von willebrand factor stably bound to collagen |
| 07/02/2002 | US6414124 Solvent extraction with alcohol and water; heating, cooling, precipitation; acidic dialysis with formic acid solution |
| 07/02/2002 | US6414123 Method for purifying FSH |
| 07/02/2002 | US6414120 Mammalian deep orange proteins |
| 07/02/2002 | US6414119 Rapidly greening, low oxygen mutant of the aequoria victoria green fluorescent protein |
| 07/02/2002 | US6414118 Amino acid sequence of chemokine induced by interferon-beta; for screening interferon mimics and suppressors |
| 07/02/2002 | US6414117 Compositions and methods for the treatment and diagnosis of immune disorders |
| 07/02/2002 | US6414116 Immunoreactive regions of glycoprotein GPII of varicella zoster virus |
| 07/02/2002 | US6414113 Amino acid sequence of peptide; for purifying and detecting bone marrow stromal cell antigen-1 |
| 07/02/2002 | US6414112 Peptide nucleic acids having 2,6-diaminopurine nucleobases |
| 07/02/2002 | US6413943 Methods and reagents for inhibiting proliferation of smooth muscle cells |
| 07/02/2002 | US6413942 Methods of delivering a physiologically active polypeptide to a mammal |
| 07/02/2002 | US6413940 Pharmaceutically active agents that impede the formation of amyloid by impeding the genesis of DMS |
| 07/02/2002 | US6413935 Oligopeptide |
| 07/02/2002 | US6413934 Biotin binding zones |
| 07/02/2002 | US6413933 Growth factor HTTER36 |
| 07/02/2002 | US6413932 Tek antagonists comprising soluble tek extracellular binding domain |
| 07/02/2002 | US6413931 Peptide inhibitor of fibrinogen blood clotting |
| 07/02/2002 | US6413777 Method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same |
| 07/02/2002 | US6413774 Producing recombinant nucleic acid using cycles of hybridization, chain extension, and denaturation; then transferring into cells for recombining |
| 07/02/2002 | US6413770 NL4 tie ligand homologue nucleic acid |
| 07/02/2002 | US6413768 Maintenance system; plasmid has restricted copy number origin of replication with transcriptional terminators, a selection marker, a post-segregational killing system, and an inducible promoter |
| 07/02/2002 | US6413764 Human metabotropic glutamate receptors, nucleic acids encoding same and uses thereof |
| 07/02/2002 | US6413762 Viral nucleotide sequences |
| 07/02/2002 | US6413759 Streptokinase mutants |
| 07/02/2002 | US6413746 Producing immunoglobulin by culturing animal hybridoma cells in presence of alkanoic acid or salt at concentration of 0.1 to 200 mm which enhances protein production but does not affect cell growth, accumulating, and recovering protein |
| 07/02/2002 | US6413743 Amino acid sequence of protein which has greater inhibition of histamine controlled cyclic amp by thioperamide than by diphenhydramine or ranitidine; nervous system disorders |
| 07/02/2002 | US6413742 Culturing recombinant host cell having dna which codes for fibrillar collagen monomer lacking a c propeptide sequence selection and alignment domain, then producing fibrillar collagen |
| 07/02/2002 | US6413741 Nucleotide sequence; for potassium channel modulators and gene therapy |
| 07/02/2002 | US6413740 Nucleic acid which codes for muscle specific kinase c-terminal fragment of human agrin; diagnosis and treatment of muscle disorders and neuromusclar disorders |
| 07/02/2002 | US6413739 AMPA-binding human GLuR3 receptors |
| 07/02/2002 | US6413738 House dust mite allergen, Der f VII, and uses therefor |
| 07/02/2002 | US6413735 Method of screening for a modulator of angiogenesis |
| 07/02/2002 | US6413731 Methods of screening for compounds which bind to a human SNORF36A receptor |
| 07/02/2002 | US6413730 Method for identifying compounds that inhibit or enhance activation of a transmembrane ligand for a receptor tyrosine kinase |
| 07/02/2002 | US6413729 Peptidoglycan recognition proteins and their production |
| 07/02/2002 | US6413728 Methods for detecting SODD genes and proteins |
| 07/02/2002 | US6413727 Detecting somatic alteration of wild-type protein in tumor tissue by immunoblotting; prognosis of cancer |
| 07/02/2002 | US6413726 Antibodies that specifically bind Cytostatin III |
| 07/02/2002 | US6413721 Methods of isolating common and specific antigens from excretory-secretory products of protostrongylidae |
| 07/02/2002 | US6413720 Method for the affinity isolation of newly synthesized RNA |
| 07/02/2002 | US6413719 KCNQ2 and KCNQ3-potassium channel genes which are mutated in benign familial neonatal convulsions (BFNC) and other epilepsies |
| 07/02/2002 | US6413550 Proteinoid carriers and methods for preparation and use thereof |
| 07/02/2002 | US6413524 spsA polynucleotides and polypeptides |
| 07/02/2002 | US6413522 Papilloma viruses, products for the detection thereof as well as for treating diseases caused by them |
| 07/02/2002 | US6413521 Helminth parasite antigen with aminopeptidase-like activity |
| 07/02/2002 | US6413518 Immunologically significant herpes simplex virus antigens and methods for identifying and using same |
| 07/02/2002 | US6413517 Identification of broadly reactive DR restricted epitopes |
| 07/02/2002 | US6413516 Suppression lymphocytes |
| 07/02/2002 | US6413514 Methods of using antibodies against human CD40 |
| 07/02/2002 | US6413511 Cartilage alterations by administering to joints chondrocytes comprising a heterologous polynucleotide |
| 07/02/2002 | US6413510 Dimeric modified groβ protein |
| 07/02/2002 | US6413509 Expansion of stem cells |
| 07/02/2002 | CA2253837C Therapeutic uses of bpi protein products for human meningococcemia |
| 07/02/2002 | CA2201714C Method for isolation of highly pure von willebrand factor |
| 07/02/2002 | CA2184908C Human osteoclast-derived cathepsin |
| 07/02/2002 | CA2167678C Radioactive peptides |